HEADER MEMBRANE ADHESION 01-JUL-99 1QUB TITLE CRYSTAL STRUCTURE OF THE GLYCOSYLATED FIVE-DOMAIN HUMAN BETA2- TITLE 2 GLYCOPROTEIN I PURIFIED FROM BLOOD PLASMA CAVEAT 1QUB MAN B 3 HAS WRONG CHIRALITY AT ATOM C1 NAG C 2 HAS WRONG CAVEAT 2 1QUB CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN (HUMAN BETA2-GLYCOPROTEIN I); COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: BETA2-GLYCOPROTEIN I SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 ORGANELLE: BLOOD PLASMA KEYWDS SHORT CONSENSUS REPEAT, SUSHI, COMPLEMENT CONTROL PROTEIN, N- KEYWDS 2 GLYCOSYLATION, MULTI-DOMAIN, MEMBRANE ADHESION EXPDTA X-RAY DIFFRACTION AUTHOR B.BOUMA,P.G.DE GROOT,J.M.H.VAN DEN ELSEN,R.B.G.RAVELLI,A.SCHOUTEN, AUTHOR 2 M.J.A.SIMMELINK,R.H.W.M.DERKSEN,J.KROON,P.GROS REVDAT 8 30-OCT-24 1QUB 1 HETSYN REVDAT 7 29-JUL-20 1QUB 1 CAVEAT COMPND REMARK HETNAM REVDAT 7 2 1 LINK SITE ATOM REVDAT 6 24-JAN-18 1QUB 1 AUTHOR REVDAT 5 13-JUL-11 1QUB 1 VERSN REVDAT 4 24-FEB-09 1QUB 1 VERSN REVDAT 3 01-APR-03 1QUB 1 JRNL REVDAT 2 14-OCT-99 1QUB 1 DBREF REVDAT 1 08-OCT-99 1QUB 0 JRNL AUTH B.BOUMA,P.G.DE GROOT,J.M.VAN DEN ELSEN,R.B.RAVELLI, JRNL AUTH 2 A.SCHOUTEN,M.J.SIMMELINK,R.H.DERKSEN,J.KROON,P.GROS JRNL TITL ADHESION MECHANISM OF HUMAN BETA(2)-GLYCOPROTEIN I TO JRNL TITL 2 PHOSPHOLIPIDS BASED ON ITS CRYSTAL STRUCTURE. JRNL REF EMBO J. V. 18 5166 1999 JRNL REFN ISSN 0261-4189 JRNL PMID 10508150 JRNL DOI 10.1093/EMBOJ/18.19.5166 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 42451 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.249 REMARK 3 FREE R VALUE : 0.269 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 2082 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.87 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 6631 REMARK 3 BIN R VALUE (WORKING SET) : 0.3990 REMARK 3 BIN FREE R VALUE : 0.3990 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.20 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 363 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.020 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2480 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 95 REMARK 3 SOLVENT ATOMS : 32 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 46.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 51.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.41 REMARK 3 ESD FROM SIGMAA (A) : 0.39 REMARK 3 LOW RESOLUTION CUTOFF (A) : 40.0 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.44 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.37 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.019 REMARK 3 BOND ANGLES (DEGREES) : 1.900 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.30 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.350 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.650 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.820 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 3.410 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 4.800 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.37 REMARK 3 BSOL : 34.79 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: USED MAXIMUM LIKELIHOOD TARGET USING REMARK 3 AMPLITUDES REMARK 4 REMARK 4 1QUB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-JUL-99. REMARK 100 THE DEPOSITION ID IS D_1000009274. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-SEP-98 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9354 REMARK 200 MONOCHROMATOR : SI(333) REMARK 200 OPTICS : TOROIDAL MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM, TRUNCATE REMARK 200 DATA SCALING SOFTWARE : CCP4 (TRUNCATE) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42497 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : 0.08900 REMARK 200 R SYM (I) : 0.08900 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 5.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.36300 REMARK 200 R SYM FOR SHELL (I) : 0.36400 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MIRAS REMARK 200 SOFTWARE USED: SOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 86.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 8.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.5 M AMMONIUM SULPHATE 20 MM CADMIUM REMARK 280 CHLORIDE 2 % (V/V) GLYCEROL 100 MM HEPES 1.5 M AMMONIUM REMARK 280 PHOSPHATE 100 MM SODIUM ACETATE, PH 7.5, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 57.25500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 57.25500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 80.58500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 83.24500 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 80.58500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 83.24500 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 57.25500 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 80.58500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 83.24500 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 57.25500 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 80.58500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 83.24500 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 11 C - N - CA ANGL. DEV. = 9.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 11 -62.29 -15.30 REMARK 500 PHE A 81 49.92 -101.59 REMARK 500 PRO A 113 -172.69 -69.38 REMARK 500 PHE A 131 50.10 -109.17 REMARK 500 ARG A 135 -73.00 -78.55 REMARK 500 ALA A 141 86.89 -172.94 REMARK 500 ARG A 148 -7.41 79.93 REMARK 500 PRO A 200 141.17 -33.79 REMARK 500 ALA A 201 42.95 -73.98 REMARK 500 LYS A 208 -9.03 75.03 REMARK 500 ALA A 252 144.96 -177.54 REMARK 500 ASN A 269 31.24 -98.13 REMARK 500 GLU A 285 -73.79 -63.76 REMARK 500 ASP A 319 108.61 61.23 REMARK 500 REMARK 500 REMARK: NULL DBREF 1QUB A 1 326 UNP P02749 APOH_HUMAN 20 345 SEQRES 1 A 319 GLY ARG THR CYS PRO LYS PRO ASP ASP LEU PRO PHE SER SEQRES 2 A 319 THR VAL VAL PRO LEU LYS THR PHE TYR GLU PRO GLY GLU SEQRES 3 A 319 GLU ILE THR TYR SER CYS LYS PRO GLY TYR VAL SER ARG SEQRES 4 A 319 GLY GLY MET ARG LYS PHE ILE CYS PRO LEU THR GLY LEU SEQRES 5 A 319 TRP PRO ILE ASN THR LEU LYS CYS THR PRO ARG VAL CYS SEQRES 6 A 319 PRO PHE ALA GLY ILE LEU GLU ASN GLY ALA VAL ARG TYR SEQRES 7 A 319 THR THR PHE GLU TYR PRO ASN THR ILE SER PHE SER CYS SEQRES 8 A 319 ASN THR GLY PHE TYR LEU ASN GLY ALA ASP SER ALA LYS SEQRES 9 A 319 CYS THR GLU GLU GLY LYS TRP SER PRO GLU LEU PRO VAL SEQRES 10 A 319 CYS ALA PRO ILE ILE CYS PRO PRO PRO SER ILE PRO THR SEQRES 11 A 319 PHE ALA THR LEU ARG VAL TYR LYS PRO SER ALA GLY ASN SEQRES 12 A 319 ASN SER LEU TYR ARG ASP THR ALA VAL PHE GLU CYS LEU SEQRES 13 A 319 PRO GLN HIS ALA MET PHE GLY ASN ASP THR ILE THR CYS SEQRES 14 A 319 THR THR HIS GLY ASN TRP THR LYS LEU PRO GLU CYS ARG SEQRES 15 A 319 GLU VAL LYS CYS PRO PHE PRO SER ARG PRO ASP ASN GLY SEQRES 16 A 319 PHE VAL ASN TYR PRO ALA LYS PRO THR LEU TYR TYR LYS SEQRES 17 A 319 ASP LYS ALA THR PHE GLY CYS HIS ASP GLY TYR SER LEU SEQRES 18 A 319 ASP GLY PRO GLU GLU ILE GLU CYS THR LYS LEU GLY ASN SEQRES 19 A 319 TRP SER ALA MET PRO SER CYS LYS ALA SER CYS LYS VAL SEQRES 20 A 319 PRO VAL LYS LYS ALA THR VAL VAL TYR GLN GLY GLU ARG SEQRES 21 A 319 VAL LYS ILE GLN GLU LYS PHE LYS ASN GLY MET LEU HIS SEQRES 22 A 319 GLY ASP LYS VAL SER PHE PHE CYS LYS ASN LYS GLU LYS SEQRES 23 A 319 LYS CYS SER TYR THR GLU ASP ALA GLN CYS ILE ASP GLY SEQRES 24 A 319 THR ILE GLU VAL PRO LYS CYS PHE LYS GLU HIS THR ASP SEQRES 25 A 319 ALA SER ASP VAL LYS PRO CYS MODRES 1QUB ASN A 143 ASN GLYCOSYLATION SITE MODRES 1QUB ASN A 164 ASN GLYCOSYLATION SITE MODRES 1QUB ASN A 174 ASN GLYCOSYLATION SITE MODRES 1QUB ASN A 234 ASN GLYCOSYLATION SITE HET NAG B 1 14 HET NAG B 2 14 HET MAN B 3 11 HET NAG C 1 14 HET NAG C 2 14 HET NAG A1431 14 HET NAG A1641 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE FORMUL 2 NAG 6(C8 H15 N O6) FORMUL 2 MAN C6 H12 O6 FORMUL 6 HOH *32(H2 O) HELIX 1 1 ILE A 263 PHE A 267 1 5 HELIX 2 2 ASP A 319 VAL A 323 5 5 SHEET 1 A 2 CYS A 4 PRO A 5 0 SHEET 2 A 2 PHE A 21 TYR A 22 -1 N TYR A 22 O CYS A 4 SHEET 1 B 3 SER A 13 VAL A 16 0 SHEET 2 B 3 GLU A 27 CYS A 32 -1 N THR A 29 O VAL A 16 SHEET 3 B 3 ARG A 43 ILE A 46 -1 O ARG A 43 N TYR A 30 SHEET 1 C 2 TYR A 36 SER A 38 0 SHEET 2 C 2 CYS A 60 PRO A 62 -1 N THR A 61 O VAL A 37 SHEET 1 D 4 GLY A 74 ARG A 77 0 SHEET 2 D 4 THR A 86 CYS A 91 -1 O SER A 88 N ARG A 77 SHEET 3 D 4 SER A 102 CYS A 105 -1 O ALA A 103 N ILE A 87 SHEET 4 D 4 TRP A 111 SER A 112 -1 O SER A 112 N LYS A 104 SHEET 1 E 2 PHE A 95 ASN A 98 0 SHEET 2 E 2 VAL A 117 PRO A 120 -1 O VAL A 117 N ASN A 98 SHEET 1 F 2 ILE A 122 CYS A 123 0 SHEET 2 F 2 SER A 145 LEU A 146 -1 N SER A 145 O CYS A 123 SHEET 1 G 3 ALA A 132 VAL A 136 0 SHEET 2 G 3 THR A 150 CYS A 155 -1 N VAL A 152 O VAL A 136 SHEET 3 G 3 THR A 166 THR A 168 -1 N ILE A 167 O ALA A 151 SHEET 1 H 2 HIS A 159 PHE A 162 0 SHEET 2 H 2 GLU A 180 GLU A 183 -1 O GLU A 180 N PHE A 162 SHEET 1 I 2 LYS A 185 CYS A 186 0 SHEET 2 I 2 LEU A 205 TYR A 206 -1 O LEU A 205 N CYS A 186 SHEET 1 J 3 GLY A 195 ASN A 198 0 SHEET 2 J 3 LYS A 210 CYS A 215 -1 O THR A 212 N ASN A 198 SHEET 3 J 3 GLU A 226 GLU A 228 -1 N ILE A 227 O ALA A 211 SHEET 1 K 2 TYR A 219 LEU A 221 0 SHEET 2 K 2 CYS A 241 ALA A 243 -1 N LYS A 242 O SER A 220 SHEET 1 L 2 THR A 253 VAL A 255 0 SHEET 2 L 2 ARG A 260 LYS A 262 -1 O VAL A 261 N VAL A 254 SHEET 1 M 2 LYS A 276 ASN A 283 0 SHEET 2 M 2 CYS A 288 GLN A 295 -1 O CYS A 288 N ASN A 283 SSBOND 1 CYS A 4 CYS A 47 1555 1555 2.10 SSBOND 2 CYS A 32 CYS A 60 1555 1555 2.10 SSBOND 3 CYS A 65 CYS A 105 1555 1555 2.08 SSBOND 4 CYS A 91 CYS A 118 1555 1555 2.11 SSBOND 5 CYS A 123 CYS A 169 1555 1555 2.07 SSBOND 6 CYS A 155 CYS A 181 1555 1555 2.11 SSBOND 7 CYS A 186 CYS A 229 1555 1555 2.66 SSBOND 8 CYS A 215 CYS A 241 1555 1555 2.11 SSBOND 9 CYS A 245 CYS A 296 1555 1555 2.10 SSBOND 10 CYS A 281 CYS A 306 1555 1555 2.09 SSBOND 11 CYS A 288 CYS A 326 1555 1555 2.06 LINK ND2 ASN A 143 C1 NAG A1431 1555 1555 1.46 LINK ND2 ASN A 164 C1 NAG A1641 1555 1555 1.44 LINK ND2 ASN A 174 C1 NAG B 1 1555 1555 1.45 LINK ND2 ASN A 234 C1 NAG C 1 1555 1555 1.44 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.39 LINK O4 NAG B 2 C1 MAN B 3 1555 1555 1.42 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.40 CISPEP 1 VAL A 16 PRO A 17 0 0.66 CISPEP 2 TYR A 83 PRO A 84 0 -0.47 CISPEP 3 SER A 112 PRO A 113 0 0.68 CRYST1 161.170 166.490 114.510 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006205 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006006 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008733 0.00000